Subscribe to RSS
DOI: 10.1055/s-0038-1642517
Influence of Six Mutations of the Protein C Gene on the Gla Domain Conformation and Calcium Affinity
Publication History
Received: 27 September 1993
Accepted after resubmission 16 February 1994
Publication Date:
09 July 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199406/lookinside/thumbnails/10-1055-s-0038-1642517-1.jpg)
Summary
The protein C Gla domain was studied in six families presenting a type II hereditary deficiency characterized by low activity in a coagulation assay and normal activity in an amidolytic assay. Five of these mutations, previously described by our group, affected Arg-5, Arg-1, Arg 229 and Ser 252. We report here the first natural Glu 7 to Asp mutation in a sixth family.
We evaluated the binding of the mutated protein C to Hn, a monoclonal antibody (mAb) known to recognize the sequence Phe 4 to Arg 9 of the Gla domain; the presence of calcium ions suppresses the recognition of this epitope by Hn. Mutation of Arg 229 to Gin and Ser 252 to Asn did not modify the inhibition of protein C binding, whereas the Arg-1 to His mutation resulted in a loss of inhibition in the presence of CaCl2. This suggests that the protein C of this patient shows impaired carboxylation.
The protein C from patients bearing the mutations Arg-5 to Trp, Arg-1 to Cys and Glu 7 to Asp bound poorly to Hn mAb, even in the absence of calcium ions. The calcium affinity of the Gla domain was studied by pseudo-affinity chromatography, in which protein C was successively eluted from a Mono Q column by CaCl210 mM and NaCl 0.6 M. Protein C from the patient bearing the Arg-5 to Asp mutation had a normal elution profile, suggesting that a modification of the propeptide cleavage site impairs the conformation of the Gla domain but not carboxylation. Conversely, the patient bearing the mutation Arg-1 to Cys had an abnormal elution profile, showing that calcium binding affinity was impaired probably due to a defective carboxylation (the behaviour of the Glu 7 to Asp mutant lacking one Gla residue validated our experimental approach).
These results confirm that mutations in the serine protease domain do not modify the conformation of the N-terminal part of the Gla domain. Arg-1 to His, Arg-1 to Cys and Glu 7 to Asp mutations strongly modified affinity for calcium ions, whereas the Arg-5 to Trp mutation probably modifies the conformation of the Gla domain.
-
References
- 1 Esmon CT. The protein C anticoagulant pathway. Arterioscleros Thrombos 1992; 12: 135-45
- 2 Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J 1992; 6: 2561-7
- 3 Patracchini P, Aiello V, Palazzi P, Calzolari E, Bemardi F. Sublocalization of the human protein C gene on chromosome 2ql3–ql4. Hum Genet 1989; 81: 191-2
- 4 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-7
- 5 Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 1986; 83: 546-50
- 6 Foster DC, Holly RD, Sprecher CA, Walker KM, Kumar AA. Endoproteolytic processing of the human protein C precursor by the yeast kex2 endopeptidase coexpressed in mammalian cells. Biochemistry 1990; 30: 367-72
- 7 Grinnell BW, Walls JD, Gerlitz B. Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J Biol Chem 1991; 266: 9778-85
- 8 Zhang L, Castellino FJ. A γ-carboxyglutamic acid (γ) variant (γ6D, γ7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 1990; 29: 10828-34
- 9 Zhang L, Jhingan A, Castellino FJ. Role of individual γ-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 1992; 80: 942-52
- 10 Suttie JW. Synthesis of vitamin K-dependent proteins. FASEB J 1993; 7: 445-52
- 11 Furie B, Furie BC. Molecular basis of vitamin K-dependent γ-carboxylation. Blood 1990; 75: 1753-62
- 12 Marlar RA, Adcock DM, Madden RM. Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification. Thromb Haemost 1990; 63: 375-9
- 13 Bovill Eg, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville I, Long GL. Protein CVermont: Symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 1992; 79: 1456-65
- 14 Ido M, Ohiwa M, Hayashi T, Nishioka J, Hatada T, Watanabe Y, Wada H, Shirakawa S, Suzuki K. A compound heterozygous protein C deficiency with a single nucleotide G deletion encoding Gly 381 and an amino acid substitution of Lys for Gla 26. Thromb Haemost 1993; 70: 636-41
- 15 Gandrille S, Alhenc-Gelas M, Gaussem P, Aillaud MF, Dupuy E, Juhan-Vague I, Aiach M. Five novel mutations located in exons III and IX of the protein C gene in patients with defective protein C anticoagulant activity. Blood 1993; 82: 159-68
- 16 Church WR, Messier T, Howard PR, Amiral J, Meyer D, Mann KG. A conserved epitope on several human vitamin K-dependent proteins: Location of the antigenic site and influence of metal ions on antibody binding. J Biol Chem 1988; 263: 6259-67
- 17 Yan SCB, Razzano P, Chao YB, Walls JD, Berg DT, Mc Clure DB, Grinnell BW. Characterization and novel purification of recombinant human protein C from three mammalian cell lines. Bio/Technology 1990; 8: 655-61
- 18 Gandrille S, Vidaud M, Aiach M, Alhenc-Gelas M, Fischer AM, Gouault-Heilman M, Toulon P, Fiessinger JN, Goossens M. Two novel mutations responsible for hereditary type I protein C deficiency. Characterization by denaturing gradient gel electrophoresis. Hum Mut 1992; 1: 491-500
- 19 Kisiel K. Isolation, characterization, and mechanism of activation by α-thrombin. J Clin Invest 1979; 64: 761-9
- 20 Zhang L, Castellino FJ. Influence of specific γ-carboxyglutamic acid residues on the integrity of the calcium-dependent conformation of human protein C. J Biol Chem 1992; 267: 26078-84
- 21 Dahlback B, Carlsson M, Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8
- 22 Diuguid DL, Rabiet M, Furie BC, Liebman HA, Furie B. Molecular basis of hemophilia B: A defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor. Proc Natl Acad Sci USA 1986; 83: 5803-7